Dr Reddy's Lab launches skin patch pain reliever in India
06 Aug 2009
Dr Reddy's Laboratories has entered the transdermal patch segment with the launch of Finrid (Fentanyl transdermal patch) in India.
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific amount of drug through the skin into the bloodstream.
Used in the management of severe to moderate pain, Finrid provides continuous systemic delivery of Fentanyl, a potent opioid analgesic for up to 72 hours. It is the first opioid transdermal patch to be developed in India, said the company press release.
Finrid will be sold through an independent distribution structure and will be available across hospitals and palliative care centres in India.
The product is available in a transdermal patch form, and delivers dosages of 25 and 50 micrograms per hour depending on the patch used.
According to the press release, one of the patch's many advantages over transdermal drug delivery is that it provides a long lasting, controlled release of the drug into the patient.